NEW YORK (GenomeWeb) – Great Basin Scientific has submitted a molecular panel assay for stool pathogens to the US Food and Drug Administration for 510(k) clearance.

The panel detects Salmonella species, Shigella species, Shiga Toxin-producing E. coli (stx1, stx 2, and O157 serotype-specific genes), and Campylobacter species (C. jejuni and C. coli) from stool samples. It requires less than two minutes of hands-on time and has a turnaround time of under two hours, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.